Investment of over US$ 500mln cuts HIV/AIDS infections in Uganda
Amb. Popp made this statement during a visit to the Masaka region to evaluate the impact of HIV prevention initiatives
MASAKA, September 17, 2024 — An annual investment of over US$500 million [approximately Shs 1.85 trillion] by the American government has significantly reduced HIV/AIDS infections in Uganda, according to U.S. Ambassador to Uganda, William W. Popp.
Amb. Popp made this statement during a visit to the Masaka region to evaluate the impact of HIV prevention initiatives. He highlighted that the reduction in HIV/AIDS cases has been achieved through a collaborative effort involving the American government, the Ugandan Ministry of Health, and the private sector.
During his visit, Popp toured the Masaka TASO Branch and K-Frank Pharmacy, one of 18 accredited pharmacies in the region authorised to distribute antiretroviral drugs [ARVs]. The U.S.A and the Infectious Disease Institute [IDI] are pioneering a model that provides free ARVs through private pharmacies.
Popp emphasised the American government’s commitment to partnering with the Ugandan government and local pharmacies to distribute free ARVs, aiming to enhance the quality of life for those living with HIV/AIDS.
With over 1.5 million people living with HIV/AIDS in Uganda, Popp noted that the free ARV distribution model through private pharmacies offers patients access to to medications 24 hours a day.
“Providing these medicines will help individuals with HIV/AIDS live longer lives without facing discrimination,” Popp said. He added that receiving ARVs through selected private pharmacies is a convenient and effective method for maintaining suppressed viral loads in patients.
The American diplomat encouraged adherence to ARV treatment, asserting that with proper medication, individuals can lead healthy, productive lives. He also commended the role of selected pharmacies in this initiative.
Dr. Bulasio Kabugo noted that many HIV/AIDS patients in the Masaka region now access drugs freely at any time. “Some patients avoid returning to their primary clinics due to stigma, but private pharmacies offer a safe alternative for obtaining free drugs,” he said.
Masaka TASO Regional Manager, Kakumba Kizito confirmed that the model of distributing free ARVs through pharmacies has been approved by the Ministry of Health and the World Health Organisation [WHO].
Paul Kavuma, Programmes Manager at IDI, revealed that this community pharmacy model benefits over 3,500 patients who receive antiretroviral therapy at their convenience, thereby reducing congestion at TASO facilities.
https://thecooperator.news/young-hiv-aids-patients-call-for-strengthened-policies-on-stigmatisation/
uy your copy of theCooperator magazine from one of our countrywide vending points or an e-copy on emag.thecooperator.news
Views: 14
